LENSAR Newsroom

BTIG Maintains LENSAR(LNSR.US) With Buy Rating, Raises Target Price to $10

Futu NewsNov 8 09:32

Lake Street Maintains LENSAR(LNSR.US) With Buy Rating, Maintains Target Price $8

Futu NewsNov 7 22:35

Lake Street Maintains LENSAR(LNSR.US) With Buy Rating, Maintains Target Price $8

Futu NewsNov 6 22:34

Lake Street Maintains LENSAR(LNSR.US) With Buy Rating, Maintains Target Price $8

Futu NewsNov 5 22:34

Lake Street Maintains LENSAR(LNSR.US) With Buy Rating, Maintains Target Price $8

Futu NewsNov 4 22:31

Lake Street Maintains LENSAR(LNSR.US) With Buy Rating, Maintains Target Price $8

Futu NewsAug 26 21:32

LENSAR (LNSR) Gets a Buy From Lake Street

TipRanksAug 26 20:47

Lake Street Maintains LENSAR(LNSR.US) With Buy Rating, Maintains Target Price $8

Futu NewsAug 6 21:32

Lake Street Maintains LENSAR(LNSR.US) With Buy Rating, Maintains Target Price $8

Futu NewsAug 5 21:33

Lake Street Keeps Their Buy Rating on LENSAR (LNSR)

TipRanksAug 5 21:01

Lake Street Sticks to Its Buy Rating for LENSAR (LNSR)

TipRanksMay 6 21:05

LENSAR Analyst Ratings

BenzingaMar 20 01:40

Lake Street Initiates Coverage On LENSAR With Buy Rating, Announces Price Target of $8

BenzingaMar 20 01:40

BTIG Keeps Their Buy Rating on LENSAR (LNSR)

TipRanksDec 31, 2023 18:19

Buy Rating Recommended for Undervalued LENSAR Amid Strong Growth and Successful ALLY Launch

TipRanksNov 10, 2023 00:35

BTIG Keeps Their Buy Rating on LENSAR (LNSR)

TipRanksMay 16, 2023 01:25

LENSAR (LNSR) Gets a Buy From BTIG

TipRanksMar 16, 2023 22:48

BTIG Reaffirms Their Buy Rating on LENSAR (LNSR)

TipRanksFeb 22, 2023 18:46

Analysts Offer Insights on Healthcare Companies: LENSAR (LNSR) and Cerevel Therapeutics Holdings (CERE)

TipRanksNov 10, 2022 02:20